Exclusive: U.S. health regulator Verma eyes new methods for drug pricing

NEW YORK (Reuters) - The U.S. government is considering setting new payment methods aimed at curbing costs for Medicare and Medicaid coverage of breakthrough medical treatments with very high prices, particularly novel gene-based therapies for cancer and other diseases, a top health official said on Thursday.


from Reuters: Top News http://ift.tt/2BBNiPQ

Share this

Related Posts

Previous
Next Post »